Research Article

Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis

Table 1

Clinical characteristics of NCFB patients with and without impaired pulmonary diffusing capacity (DLCO <80% prediction and DLCO/VA <80% prediction) and decreased alveolar volume (VA <80% prediction).

Total (n)Impaired diffusing capacity diagnosed by DLCO valueImpaired diffusing capacity diagnosed by DLCO/VA valueDecreased VA value
≥80% prediction<80% prediction≥80% prediction<80% prediction≥80% prediction<80% prediction

Number1759481134418590
Age (years)175 (100%)58.17 ± 12.5366.84 ± 11.68<0.00160.66 ± 12.5967.17 ± 12.610.00458.62 ± 13.4365.54 ± 11.39<0.001
Sex, male106 (60.5%)53 (56.4%)53 (65.4%)0.2277 (57.5%)29 (70.7%)0.12841 (48.2%)65 (72.2%)0.001
Hemoglobin (g/L)175 (100%)133.17 ± 17.36125.99 ± 16.840.006131.29 ± 12.60135.10 ± 12.610.047129.98 ± 17.12129.69.10 ± 17.830.914
Duration of disease (years)175 (100%)0.84 (0.00, 5.00)6.00 (1.75, 10.00)<0.0012.00 (0, 6.00)10.00 (5.00, 12.50)<0.0012.00 (0, 7.00)5.00 (0, 10.00)0.006
Modified Reiff score175 (100%)5.00 (3.00, 8.00)8.00 (5.00, 12.00)<0.0016.00 (4.00, 9.25)8.00 (4.00, 12.00)0.0375.00 (3.00, 8.00)8.00 (5.00, 11.00)<0.001
Frequency of hospitalization in the last 2 years175 (100%)1.00 (1.00, 1.00)1.00 (1.00, 2.00)0.021.00 (1.00, 1.00)2.00 (1.00, 2.00)<0.0011.00 (1.00, 1.00)2.00 (1.00, 2.00)0.108
Frequency of exacerbation in the last 2 years175 (100%)1.00 (1.00, 2.00)2.00 (1.00, 3.00)<0.0011.00 (1.00, 2.00)3.00 (1.50, 3.00)<0.0011.00 (1.00, 2.00)2.00 (1.00, 3.00)0.083
Body mass index (kg/m2)
 <18.534 (19.4%)9 (9.6%)25 (30.9%)<0.00119 (14.2%)15 (36.6%)0.00311 (12.9%)23 (25.6%)0.031
 18.5∼2485 (48.6%)43 (45.7%)42 (51.9%)66 (49.3%)19 (46.3%)40 (47.1%)45 (50.0%)
 ≥2456 (32.0%)42 (44.7%)14 (17.3%)49 (36.6%)7 (17.1%)34 (40.0%)22 (24.4%)
Smoking status
 Smoker or ex-smoker77 (44.0%)32 (34.0%)45 (55.6%)0.00553 (39.6%)24 (58.5%)0.03228 (32.9%)49 (54.4%)0.004
 Nonsmoker98 (56.0%)62 (66.0%)37 (44.4%)81 (60.4%)17 (41.5%)57 (67.1%)41 (45.6%)
Pseudomonas aeruginosa colonization
 Yes12 (6.9%)3 (3.2%)9 (11.1%)0.048 (6.0%)4 (9.8%)0.6274 (4.7%)8 (8.9%)0.274
 No163 (93.2%)91 (96.8%)72 (88.9%)126 (94.0%)37 (90.2%)81 (95.3%)82 (91, 1%)
Lower airway pathogen detection
 None122 (69.7%)72 (76.6%)50 (61.7%)0.0897 (72.4%)25 (61.0%)0.21264 (75.3%)58 (64.4%)0.187
Pseudomonas aeruginosa22 (12.61%)8 (8.5%)14 (17.3%)17 (12.7%)5 (12.2%)7 (8.2%)15 (16.7%)
 Other pathogen31 (18.9%)14 (14.9%)17 (21.0%)20 (14.9%)11 (26.8%)14 (16.5%)17 (18.9%)
Chronic obstructive pulmonary disease
 Yes64 (36.6%)20 (21.3%)44 (54.3%)<0.00135 (26.1%)29 (70.7%)<0.00123 (27.1%)41 (45.6%)0.011
 No111 (63.4%)74 (78.7%)37 (45.7%)99 (73.9%)12 (29.3%)62 (72.9%)49 (54.4%)
Asthma
 Yes20 (11.4%)16 (17.0%)4 (4.9%)0.0118 (13.4%)2 (4.9%)0.22013 (15.3%)7 (7.8%)0.118
 No155 (88.6%)78 (83.0%)77 (95.1%)116 (86.6%)39 (95.1%)72 (84.7%)83 (92.2%)
Interstitial lung disease
 Yes13 (7.4%)1 (7.7%)12 (92.3%)0.0018 (6.0%)5 (12.2%)0.3224 (4.7%)9 (10.0%)0.182
 No162 (92.6%)93 (57.4%)69 (42.6%)126 (94.0%)36 (87.8%)81 (95.3%)81 (90.0%)
Pulmonary arterial hypertension
 Yes27 (15.4%)4 (4.3%)23 (28.4%)0.0018 (6.0%)5 (12.2%)<0.0018 (9.4%)19 (21.1%)0.032
 No148 (84.6%)90 (95.7%)58 (71.6%)126 (94.0%)36 (87.8%)77 (90.6%)71 (78.9%)
Cardiovascular diseases
 Yes56 (32.0%)23 (25.3%)33 (40.7%)0.0238 (28.4%)18 (43.9%)0.06225 (29.4%)31 (34.4%)0.476
 No119 (68.0%)71 (74.7%)48 (59.3%)96 (71.6%)23 (56.1%)60 (70.6%)59 (65.6%)
Diabetes mellitus
 Yes20 (11.4%)12 (12.8%)8 (9.9%)0.5516 (11.9%)4 (9.8%)0.91711 (12.9%)9 (10.0%)0.541
 No155 (88.6%)82 (87.2%)73 (90.1%)118 (88.1%)37 (90.2%)74 (87.1%)81 (90.0%)
Gastroesophageal reflux disease
 Yes21 (12.0%)12 (12.8%)9 (11.1%)0.7417 (12.7%)4 (9.8%)0.8187 (8.2%)14 (15.6%)0.136
 No154 (88.0%)82 (87.2%)72 (88.9%)117 (87.3%)37 (90.2%)78 (91.8%)76 (84.4%)
Other complications
 Yes85 (48.6%)48 (51.1%)37 (45.7%)0.4865 (48.5%)20 (48.8%)0.97641 (48.2%)44 (48.9%)0.931
 No90 (51.4%)46 (48.9%)44 (54.3%)69 (51.5%)21 (51.2%)44 (51.8%)46 (51.1%)
Bronchi cystic dilation
 Yes92 (52.6%)43 (45.7%)49 (60.5%)0.0567 (50.0%)25 (61.0%)0.21840 (47.1%)52 (57.8%)0.156
 No83 (47.4%)51 (54.3%)32 (39.5%)67 (50.0%)16 (39.0%)45 (52.9%)38 (42.2%)
Bronchi varicose dilation
 Yes110 (62.9%)55 (58.5%)55 (67.9%)0.2083 (61.9%)27 (65.9%)0.65052 (61.2%)58 (64.4%)0.655
 No65 (37.1%)39 (41.5%)26 (32.1%)51 (38.1%)14 (34.1%)33 (38.8%)32 (35.6%)
Bronchi column dilation
 Yes122 (69.7%)65 (69.1%)57 (70.4%)0.8692 (68.7%)30 (73.2%)0.58259 (69.4%)63 (70.0%)0.933
 No53 (30.3%)29 (30.9%)25 (29.7%)42 (31.3%)11 (26.8%)26 (30.6%)27 (30.0%)